Showing results (171-180 of 697) with videos related to
Sort By:
Pageof 70
Journal of the American College of Cardiology|December 1, 1986
Pharmacology of thrombolytic drugsM Verstraete, D CollenThe American Journal of Physiology|December 31, 1997
Molecular analysis of blood vessel formation and diseaseP Carmeliet, D CollenSeminars in Thrombosis and Hemostasis|January 1, 1996
Gene manipulation and transfer of the plasminogen and coagulation system in miceP Carmeliet, D CollenThrombosis and Haemostasis|May 1, 1996
Comparative effects of staphylokinase and alteplase in rabbit bleeding time modelsS Vanderschueren, D CollenThrombosis and Haemostasis|October 1, 1981
Neutralization of human extrinsic (tissue-type) plasminogen activator in human plasma: no evidence for a specific inhibitorC Korninger, D CollenThe International Journal of Biochemistry & Cell Biology|August 8, 1998
Tissue factorP Carmeliet, D CollenJournal of Acquired Immune Deficiency Syndromes|January 1, 1992
Endothelial cell dysfunction in HIV infectionA Lafeuillade, M C Alessi, I Poizot-Martin, et al.International Journal of Obesity (2005)|October 14, 2009
Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME StudyG Luc, J-P Empana, P Morange, et al.Blood|February 13, 2001
The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A-like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factorA N Ribba, L Hilbert, J M Lavergne, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1997
Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy populationM Henry, N Chomiki, P Y Scarabin, et al.Pageof 70